Medline Inc.
Organization details
- Legal name
- Medline Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Northfield
- Headquarters state / province
- Illinois
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MDLN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002046386
- EIN
- 33-1845288
Board of directors
-
Andrew J. Mills · DirectorSince 2025
-
Anushka M. Sunder · DirectorSince 2025
-
Charles N. Mills · DirectorSince 2025
-
Jacob Best · DirectorSince 2025
-
James M. Boyle · Director · Chief Executive OfficerSince 2025
-
Joseph Baratta · DirectorSince 2025
-
Patrick J. Healy · DirectorSince 2025
-
Richard A. Galanti · DirectorSince 2025
-
Robert R. Schmidt · DirectorSince 2025
-
Stephen H. Wise · DirectorSince 2025
-
Thomas W. Sweet · DirectorSince 2025
-
Todd M. Bluedorn · DirectorSince 2025
Chief executives
Outstanding · grade A
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 82
11.5% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.3%
-
99.1%
-
99.3%
-
99.3%
-
99.3%
-
99.3%
-
99.4%
-
99.6%
-
99.6%
-
99.6%
-
99.6%
-
99.6%
Board connections
4 of this board's directors also sit on 7 other boards. 1 is in the same sector.
-
3M Company Same sectorvia Thomas W. Sweet
- via Richard A. Galanti
- via Joseph Baratta
- via Richard A. Galanti
- via Todd M. Bluedorn
- via Todd M. Bluedorn
- via Thomas W. Sweet
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $514,970,688
- 5 purchases by 4 insiders
- Sold, last 12 months
- $10,581,918,939
- 46 sales by 14 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 8, 2026 | GIC Private Ltd 10% owner | Open-market sale | −7,816,987 | $35.15 | $274,767,093 |
| Oct 6, 2026 | GIC Private Ltd 10% owner | Open-market sale | −2,088,987 | $35.05 | $73,218,994 |
| Oct 6, 2026 | GIC Private Ltd 10% owner | Open-market sale | −7,183,013 | $35.05 | $251,764,606 |
| Oct 5, 2026 | GIC Private Ltd 10% owner | Open-market sale | −1,688,690 | $35.78 | $60,421,328 |
| Oct 2, 2026 | GIC Private Ltd 10% owner | Open-market sale | −2,570,999 | $35.35 | $90,884,815 |
| Oct 2, 2026 | GIC Private Ltd 10% owner | Open-market sale | −7,146,941 | $34.33 | $245,354,485 |
| Aug 14, 2026 | Hux Investment Pte. Ltd. 10% owner | Open-market sale | −100,000 | $35.80 | $3,580,000 |
| Aug 13, 2026 | Hux Investment Pte. Ltd. 10% owner | Open-market sale | −1,500,000 | $35.80 | $53,700,000 |
| Aug 7, 2026 | GIC Private Ltd 10% owner | Open-market sale | −590,284 | $35.58 | $21,002,305 |
| Aug 6, 2026 | Mozart Holdco, Inc. 10% owner | Derivative conversion | +500,000 | — | — |
| Aug 6, 2026 | Mozart Holdco, Inc. 10% owner | Other | −500,000 | — | — |
| Aug 6, 2026 | Hux Investment Pte. Ltd. 10% owner | Open-market sale | −271,994 | $35.33 | $9,609,548 |
| Aug 5, 2026 | Hux Investment Pte. Ltd. 10% owner | Open-market sale | −1,710,907 | $35.46 | $60,668,762 |
| Aug 5, 2026 | Hux Investment Pte. Ltd. 10% owner | Open-market sale | −265,711 | $36.48 | $9,693,137 |
| Jun 16, 2026 | Golwas Douglas P Officer (Chief Commercial Officer), 10% owner | Option exercise | +100,000 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Medline Inc.
Who is the CEO of Medline Inc.?
James M. Boyle has been Medline Inc.'s Chief Executive Officer since December 2025.
How many directors are on Medline Inc.'s board?
Medline Inc.'s board has 12 directors: Andrew J. Mills, Anushka M. Sunder, Charles N. Mills, Jacob Best, James M. Boyle, Joseph Baratta, Patrick J. Healy, Richard A. Galanti, Robert R. Schmidt, Stephen H. Wise and 2 others.
Are Medline Inc. insiders buying or selling shares?
Over the last 12 months, Medline Inc. insiders bought $515.0 million of shares in 5 purchases and sold $10.6 billion of shares in 46 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="medline-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.